Heron End Period Cash Flow from 2010 to 2024

HRTX Stock  USD 1.19  0.03  2.59%   
Heron Therapeuti End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow will likely drop to about 28.5 M in 2024. During the period from 2010 to 2024, Heron Therapeuti End Period Cash Flow regression line of annual values had r-squared of  0.01 and arithmetic mean of  54,943,520. View All Fundamentals
 
End Period Cash Flow  
First Reported
1989-09-30
Previous Quarter
18.4 M
Current Value
25.7 M
Quarterly Volatility
43.1 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Heron Therapeuti over the last few years. It is Heron Therapeuti's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Very volatile
   End Period Cash Flow   
       Timeline  

Heron End Period Cash Flow Regression Statistics

Arithmetic Mean54,943,520
Geometric Mean38,130,332
Coefficient Of Variation72.90
Mean Deviation33,026,315
Median53,506,000
Standard Deviation40,051,918
Sample Variance1604.2T
Range142M
R-Value0.09
Mean Square Error1712.1T
R-Squared0.01
Significance0.74
Slope846,177
Total Sum of Squares22458.2T

Heron End Period Cash Flow History

202428.5 M
202328.7 M
202215.4 M
202190.5 M
2020105.1 M
201971.9 M
201831.8 M

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow28.7 M28.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.